Literature DB >> 15566352

Bleeding and bruising in patients with Ehlers-Danlos syndrome and other collagen vascular disorders.

Anne De Paepe1, Fransiska Malfait.   

Abstract

Easy bruising and bleeding are not only characteristic manifestations of clotting and platelet disorders, they are also prominent features in some heritable collagen disorders, such as the Ehlers-Danlos syndromes (EDS). The EDS comprise a heterogeneous group of connective tissue diseases sharing clinical manifestations in skin, ligaments and joints, blood vessels and internal organs. Most EDS subtypes are caused by mutations in genes encoding the fibrillar collagens type I, III and V, or in genes coding for enzymes involved in the post-translational modification of these collagens. Easy bruising is, to a variable degree, present in all subtypes of EDS, and is because of fragility of the capillaries and the perivascular connective tissues. Vascular fragility affecting medium-sized and large arteries and veins is typically observed in the vascular subtype of EDS, caused by a molecular defect in collagen type III, an important constituent of blood vessel walls and hollow organs. Extensive bruising, spontaneous arterial rupture, leading to severe internal bleeding or premature death, and rupture of hollow organs, such as the intestine or the gravid uterus are predominant features of this subtype. Haematological studies including evaluation of clotting factors, platelet aggregation and bleeding time are usually normal in patients with EDS, except for the Hess test (Rumple-Leede test), which may be abnormal, indicating capillary fragility. In some forms of EDS confirmation of the clinical diagnosis and subtype is possible with biochemical and molecular studies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15566352     DOI: 10.1111/j.1365-2141.2004.05220.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  36 in total

1.  Facelift for an Ehlers-Danlos Syndrome Patient: A Case Report.

Authors:  Rebecca Rollett; Russell James Bramhall; Muhammad Adil Abbas Khan; Muhammad Riaz
Journal:  Aesthet Surg J       Date:  2016-03       Impact factor: 4.283

Review 2.  Evaluation and management of heavy menstrual bleeding in adolescents: the role of the hematologist.

Authors:  Sarah H O'Brien
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

Review 3.  Ehlers-Danlos syndrome (EDS) type IV: review of the literature.

Authors:  Cristiano Macabu Badauy; Sabrina S Gomes; Manoel Sant'Ana Filho; José Artur Bogo Chies
Journal:  Clin Oral Investig       Date:  2007-01-13       Impact factor: 3.573

4.  Spontaneous bilateral patellar tendon rupture: a case report and review of the literature.

Authors:  Biagio Moretti; Angela Notarnicola; Lorenzo Moretti; Raffaele Garofalo; Vittorio Patella
Journal:  Chir Organi Mov       Date:  2008-02-10

5.  Proprioceptive sensitivity in Ehlers-Danlos syndrome patients.

Authors:  Holly A Clayton; Erin K Cressman; Denise Y P Henriques
Journal:  Exp Brain Res       Date:  2013-08-03       Impact factor: 1.972

Review 6.  Periventricular heterotopia: new insights into Ehlers-Danlos syndrome.

Authors:  Volney L Sheen; Christopher A Walsh
Journal:  Clin Med Res       Date:  2005-11

Review 7.  Vascular wall extracellular matrix proteins and vascular diseases.

Authors:  Junyan Xu; Guo-Ping Shi
Journal:  Biochim Biophys Acta       Date:  2014-07-18

8.  Testicular torsion in a patient with Ehlers-Danlos syndrome.

Authors:  Amy Lee Fowler; David Bouchier Hayes; Eszter Feher
Journal:  BMJ Case Rep       Date:  2018-03-22

9.  The vascular Ehlers-Danlos syndrome.

Authors:  Dominique P Germain
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-04

10.  Pathology of the large intestine in patients with vascular type Ehlers-Danlos syndrome.

Authors:  Hendrik Bläker; Benjamin Funke; Ingrid Hausser; Thilo Hackert; Peter Schirmacher; Frank Autschbach
Journal:  Virchows Arch       Date:  2007-05-09       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.